Oncology Institute (TOIIW) Competitors $0.06 -0.02 (-23.63%) As of 04/30/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock TOIIW vs. ACONW, AONC, DHACW, LFMDP, OTRKP, PIIIW, TALKW, NTRA, FMS, and HIMSShould you be buying Oncology Institute stock or one of its competitors? The main competitors of Oncology Institute include Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Natera (NTRA), Fresenius Medical Care (FMS), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry. Oncology Institute vs. Aclarion American Oncology Network Digital Health Acquisition LifeMD Ontrak P3 Health Partners Talkspace Natera Fresenius Medical Care Hims & Hers Health Aclarion (NASDAQ:ACONW) and Oncology Institute (NASDAQ:TOIIW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation, media sentiment, earnings and community ranking. Which has better earnings & valuation, ACONW or TOIIW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$45.72KN/AN/AN/AN/AOncology Institute$393.41MN/AN/AN/AN/A Is ACONW or TOIIW more profitable? Company Net Margins Return on Equity Return on Assets AclarionN/A N/A N/A Oncology Institute N/A N/A N/A Does the media favor ACONW or TOIIW? In the previous week, Oncology Institute had 1 more articles in the media than Aclarion. MarketBeat recorded 2 mentions for Oncology Institute and 1 mentions for Aclarion. Aclarion's average media sentiment score of 1.87 beat Oncology Institute's score of 0.77 indicating that Aclarion is being referred to more favorably in the media. Company Overall Sentiment Aclarion Very Positive Oncology Institute Positive Does the MarketBeat Community believe in ACONW or TOIIW? Aclarion and Oncology Institute both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAclarionN/AN/AOncology InstituteN/AN/A SummaryOncology Institute beats Aclarion on 2 of the 3 factors compared between the two stocks. Get Oncology Institute News Delivered to You Automatically Sign up to receive the latest news and ratings for TOIIW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TOIIW vs. The Competition Export to ExcelMetricOncology InstituteMedical Care Facilities IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$1.48B$5.56B$7.82BDividend YieldN/A3.83%5.11%4.22%P/E RatioN/A6.9722.5118.48Price / SalesN/A11.85395.68103.60Price / CashN/A12.5138.1834.62Price / BookN/A1.876.774.25Net IncomeN/A$58.65M$3.22B$248.23M7 Day PerformanceN/A-1.33%1.45%0.89%1 Month PerformanceN/A-1.69%3.97%3.53%1 Year PerformanceN/A9.34%16.14%5.08% Oncology Institute Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TOIIWOncology InstituteN/A$0.06-23.6%N/A-69.0%$0.00$393.41M0.00660Short Interest ↓News CoverageACONWAclarionN/A$0.05-8.9%N/A-48.0%$0.00$45,724.000.007Positive NewsGap DownAONCAmerican Oncology NetworkN/A$5.11-14.8%N/A+64.9%$0.00$1.34B0.001,520Positive NewsHigh Trading VolumeDHACWDigital Health AcquisitionN/A$0.04flatN/AN/A$0.00N/A0.00N/ALFMDPLifeMDN/A$23.81-3.6%N/A+8.8%$0.00$212.45M0.00230Upcoming EarningsShort Interest ↑OTRKPOntrakN/A$0.23-6.0%N/A-45.6%$0.00$10.84M0.00250Gap DownPIIIWP3 Health PartnersN/A$0.02+35.6%N/A-80.3%$0.00$1.50B0.00500Gap UpTALKWTalkspaceN/A$0.09-9.1%N/A-57.1%$0.00$187.59M0.00500NTRANatera2.8621 of 5 stars$144.62+1.7%$175.76+21.5%+62.5%$19.55B$1.70B-82.173,020Upcoming EarningsInsider TradePositive NewsGap DownFMSFresenius Medical Care3.8408 of 5 stars$23.99+2.0%$25.30+5.4%+20.6%$13.80B$19.34B19.83123,200Upcoming EarningsPositive NewsHigh Trading VolumeHIMSHims & Hers Health3.1908 of 5 stars$25.41-1.7%$38.25+50.5%+164.1%$5.65B$1.48B57.75650Upcoming EarningsAnalyst ForecastInsider TradeOptions VolumeNews CoverageGap Down Related Companies and Tools Related Companies ACONW Alternatives AONC Alternatives DHACW Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives NTRA Alternatives FMS Alternatives HIMS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TOIIW) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TOIIW Stock Free TOIIW Stock Alerts